Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma
NATURE COMMUNICATIONS
Authors: Li, Zhaoming; Zhang, Xudong; Xue, Weili; Zhang, Yanjie; Li, Chaoping; Song, Yue; Mei, Mei; Lu, Lisha; Wang, Yingjun; Zhou, Zhiyuan; Jin, Mengyuan; Bian, Yangyang; Zhang, Lei; Wang, Xinhua; Li, Ling; Li, Xin; Fu, Xiaorui; Sun, Zhenchang; Wu, Jingjing; Nan, Feifei; Chang, Yu; Yan, Jiaqin; Yu, Hui; Feng, Xiaoyan; Wang, Guannan; Zhang, Dandan; Fu, Xuefei; Zhang, Yuan; Young, Ken H.; Li, Wencai; Zhang, Mingzhi
Abstract
Natural killer/T cell lymphoma (NKTCL) is a rare and aggressive malignancy with a higher prevalence in Asia and South America. However, the molecular genetic mechanisms underlying NKTCL remain unclear. Here, we identify somatic mutations of GNAQ (encoding the T96S alteration of G alpha q protein) in 8.7% (11/127) of NKTCL patients, through whole-exome/targeted deep sequencing. Using conditional knockout mice (Ncr1-Cre-Gnaq(fl/fl)), we demonstrate that G alpha q deficiency leads to enhanced NK cell survival. We also find that G alpha q suppresses tumor growth of NKTCL via inhibition of the AKT and MAPK signaling pathways. Moreover, the G alpha q T96S mutant may act in a dominant negative manner to promote tumor growth in NKTCL. Clinically, patients with GNAQ T96S mutations have inferior survival. Taken together, we identify recurrent somatic GNAQ T96S mutations that may contribute to the pathogenesis of NKTCL. Our work thus has implications for refining our understanding of the genetic mechanisms of NKTCL and for the development of therapies.
Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity
CELL REPORTS
Authors: Wagner, Julia A.; Wong, Pamela; Schappe, Timothy; Berrien-Elliott, Melissa M.; Cubitt, Celia; Jaeger, Natalia; Lee, Madeline; Keppel, Cassie R.; Marin, Nancy D.; Foltz, Jennifer A.; Marsala, Lynne; Neal, Carly C.; Sullivan, Ryan P.; Schneider, Stephanie E.; Keppel, Molly P.; Saucier, Nermina; Cooper, Megan A.; Fehniger, Todd A.
Abstract
Natural killer (NK) cells are cytotoxic innate lymphoid cells (ILCs) that mediate antiviral and antitumor responses and require the transcriptional regulator Eomesodermin (Eomes) for early development, However, the role of Eomes and its molecular program in mature NK cell biology is unclear To address this, we develop a tamoxifen-inducible, type-I -ILC-specific (Ncr1-targeted) cre mouse and combine this with Eomes-floxed mice. Eomes deletion after normal NK cell ontogeny results in a rapid loss of NK cells (but not ILC1s), with a particularly profound effect on penultimately mature stage III NK cells. Mechanisms responsible for stage III reduction include increased apoptosis and impaired maturation from stage II precursors. Induced Eomes deletion also decreases NK cell cytotoxicity and abrogates in vivo rejection of major histocompatibility complex (MHC)-class-I-deficient cells. However, other NK cell functional responses, and stage IV NK cells, are largely preserved. These data indicate that mature NK cells have distinct Eomes-dependent and -independent stages.